BioStem's Q4-2024 revenue expected to rise 794% YoY, with full-year net revenue increasing 1,702%. Read why I'm bullish on ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and ...

Cresco Labs CRLBF reported fourth-quarter revenue of $175.91 million, surpassing estimates of $172.13 million but marking a ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

Billions of clinical insights—once buried in an unusable format—may now be used to train large language models and inform clinical research studies.

Complex terminology, omissions, and inconsistencies frustrate physicians. A study reveals necessary improvements — will ...

Google unveiled new capabilities in healthcare March 18 at its “The Check Up” event, including medical records application ...

From brain health — through good sleep habits — to daily skin and dental care regimens, these experts provide simple tips for ...

UCSF is recognized globally for innovative treatments, advanced technology and pioneering research applied to patient ... toughest health challenges. From primary care to the most complex conditions, ...

Amortization is an important concept not just to economists, but to any company figuring out its balance sheet. Amortization is an accounting method that calculates the expenses incurred by an ...

2-Year U.S. Treasury Note Continuous Contract $103.508 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $107.969 0.047 0.04% 10-Year U.S. Treasury Note Continuous Contract $111.125 0.125 ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...